目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?

8 Company Profiles
8.1. Merck & Co Inc
8.2. AbbVie Inc
8.3. AstraZeneca Plc
8.4. Johnson & Johnson
8.5. Bayer AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Global biotechnology industry value: $ billion, 2019-24
Table 2: Global biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Global biotechnology industry category segmentation: $ billion, 2019-24
Table 4: Global biotechnology industry geography segmentation: $ billion, 2024
Table 5: Global biotechnology industry value forecast: $ billion, 2024-29
Table 6: Merck & Co Inc: Key Facts
Table 7: Merck & Co Inc: Annual Financial Ratios
Table 8: Merck & Co Inc: Key Employees
Table 9: AbbVie Inc: Key Facts
Table 10: AbbVie Inc: Annual Financial Ratios
Table 11: AbbVie Inc: Key Employees
Table 12: AbbVie Inc: Key Employees Continued
Table 13: AstraZeneca Plc: Key Facts
Table 14: AstraZeneca Plc: Annual Financial Ratios
Table 15: AstraZeneca Plc: Key Employees
Table 16: Johnson & Johnson: Key Facts
Table 17: Johnson & Johnson: Annual Financial Ratios
Table 18: Johnson & Johnson: Key Employees
Table 19: Bayer AG: Key Facts
Table 20: Bayer AG: Annual Financial Ratios
Table 21: Bayer AG: Key Employees
Table 22: Bayer AG: Key Employees Continued
Table 23: Bayer AG: Key Employees Continued
Table 24: Global Exchange Rate, 2019-24

List of Figures
Figure 1: Global biotechnology industry value: $ billion, 2019-24
Figure 2: Global biotechnology industry category segmentation: $ billion, 2019-24
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Global biotechnology industry value forecast: $ billion, 2024-29
Figure 5: Forces driving competition in the global biotechnology industry, 2024
Figure 6: Drivers of buyer power in the global biotechnology industry, 2024
Figure 7: Drivers of supplier power in the global biotechnology industry, 2024
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2024
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2024
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2024